
## INDUCTION: HIGH RISK ALL 

This therapy is for all patients with NCI high risk B-ALL and T ALL only once able to safely administer

Induction lasts 5 weeks (35 days). This Therapy Delivery Map is on one (1) page. Patients should remain hospitalized during induction and receive antifungal and antibacterial prophylaxis.

**VinCRIStine (VCR)**
-	Route: IV push over 1 minute
-	Dosage: 1.5 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Days 1, 8, 15, & 22 
-	Caution: Maximum dose: 2 mg

**Dexamethasone (DEX)**
-	Route: PO (may give IV)
-	Dosage: 5 mg/m2/dose BID
-	Used on Days 1-14 (do not taper) (28 doses)
-	Caution: Total daily dose: 10 mg/m2/day, divided BID for children. Use only for children < 10 years

**Prednisone (PRED)**
-	Route: PO (may give IV)
-	Dosage: 30 mg/m2/dose BID
-	Used on Days 1-28 (do not taper) (56 doses)
-	Caution: Total daily dose: 60 mg/m2/day, divided BID. Use only for children â‰¥10 years of age and all T-ALL

**L-asparaginase**
-	Route: IM
-	Dosage: 6000 International Units/m2/dose (9 doses, MWF)
-	Used on: Day 2, 4, 6, Day 8, 10, 12, Day 15, 17, 19
-	Caution: Monitor for one hour after dose for any signs/symptoms of allergic reaction/anaphylaxis

**Daunorubicin (DAUNO)**
-	Route: IV Push/infusion over 1-15 min
-	Dosage: 25 mg/m2/dose
-   Dilute with 30ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Days 1, 8, 15, 22
-	Caution: Can substitute with doxorubicin at same dose if daunorubicin unavailable

Begin next course Consolidation on Day 36 or when blood count parameters are met (whichever occurs later).
Only CNS2/3 patients should receive IT MTX on day 15 and 22 ^End of induction bone marrow for pre-B ALL only
